Literature DB >> 11326269

A novel maternally expressed gene, ATP10C, encodes a putative aminophospholipid translocase associated with Angelman syndrome.

M Meguro1, A Kashiwagi, K Mitsuya, M Nakao, I Kondo, S Saitoh, M Oshimura.   

Abstract

Lack of a maternal contribution to the genome at the imprinted domain on proximal chromosome 15 causes Angelman syndrome (AS) associated with neurobehavioral anomalies that include severe mental retardation, ataxia and epilepsy. Although AS patients have infrequent mutations in the gene encoding an E6-AP ubiquitin ligase required for long-term synaptic potentiation (LTP), most cases are attributed to de novo maternal deletions of 15q11-q13. We report here that a novel maternally expressed gene, ATP10C, maps within the most common interval of deletion and that ATP10C expression is virtually absent from AS patients with imprinting mutations, as well as from patients with maternal deletions of 15q11-q13.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11326269     DOI: 10.1038/ng0501-19

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  59 in total

1.  The human aminophospholipid-transporting ATPase gene ATP10C maps adjacent to UBE3A and exhibits similar imprinted expression.

Authors:  L B Herzing; S J Kim; E H Cook ; D H Ledbetter
Journal:  Am J Hum Genet       Date:  2001-05-11       Impact factor: 11.025

2.  On the conflicting reports of imprinting status of mouse ATP10a in the adult brain: strain-background-dependent imprinting?

Authors:  Tomohiko Kayashima; Tohru Ohta; Norio Niikawa; Tatsuya Kishino
Journal:  J Hum Genet       Date:  2003-09-04       Impact factor: 3.172

3.  High concentrations of long interspersed nuclear element sequence distinguish monoallelically expressed genes.

Authors:  Elena Allen; Steve Horvath; Frances Tong; Peter Kraft; Elizabeth Spiteri; Arthur D Riggs; York Marahrens
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-08       Impact factor: 11.205

4.  Critical role of a transmembrane lysine in aminophospholipid transport by mammalian photoreceptor P4-ATPase ATP8A2.

Authors:  Jonathan A Coleman; Anna L Vestergaard; Robert S Molday; Bente Vilsen; Jens Peter Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

5.  Microarray analysis of gene/transcript expression in Angelman syndrome: deletion versus UPD.

Authors:  Douglas C Bittel; Nataliya Kibiryeva; Zohreh Talebizadeh; Daniel J Driscoll; Merlin G Butler
Journal:  Genomics       Date:  2005-01       Impact factor: 5.736

6.  Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.

Authors:  Rodney C Samaco; Amber Hogart; Janine M LaSalle
Journal:  Hum Mol Genet       Date:  2004-12-22       Impact factor: 6.150

7.  Narrowed abrogation of the Angelman syndrome critical interval on human chromosome 15 does not interfere with epigenotype maintenance in somatic cells.

Authors:  Masayuki Haruta; Makiko Meguro; Yu-Ki Sakamoto; Hidetoshi Hoshiya; Akiko Kashiwagi; Yasuhiko Kaneko; Kohzoh Mitsuya; Mitsuo Oshimura
Journal:  J Hum Genet       Date:  2005-03-03       Impact factor: 3.172

8.  Predominant maternal expression of the mouse Atp10c in hippocampus and olfactory bulb.

Authors:  Akiko Kashiwagi; Makiko Meguro; Hidetoshi Hoshiya; Masayuki Haruta; Fumitoshi Ishino; Toshiyuki Shibahara; Mitsuo Oshimura
Journal:  J Hum Genet       Date:  2003-03-12       Impact factor: 3.172

9.  Localization, purification, and functional reconstitution of the P4-ATPase Atp8a2, a phosphatidylserine flippase in photoreceptor disc membranes.

Authors:  Jonathan A Coleman; Michael C M Kwok; Robert S Molday
Journal:  J Biol Chem       Date:  2009-09-24       Impact factor: 5.157

10.  An essential subfamily of Drs2p-related P-type ATPases is required for protein trafficking between Golgi complex and endosomal/vacuolar system.

Authors:  Zhaolin Hua; Parvin Fatheddin; Todd R Graham
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.